Attitudes of Those at Risk for Huntington's Disease toward Presymptomatic Provocative Testing

Michael K. Mccormack, Alice Lazzarini

Research output: Contribution to journalLetterpeer-review

9 Scopus citations

Abstract

To the Editor: Klawans et al.1 originally reported on the potential use of levodopa loading to predict the presence of the gene for Huntington's disease in at-risk subjects, and an eight-year follow-up study2 demonstrated a prognostic capability for this test. Fahn3 pointed out several problems with provocative testing with levodopa, including the psychological consequences of inducing transient chorea symptoms in subjects, which might result in suicide. He suggested that the ideal test would be one in which the subject would be unaware of the results. Bates,4 however, maintained that the results of presymptomatic tests should not be withheld from.

Original languageEnglish (US)
Number of pages1
JournalNew England Journal of Medicine
Volume307
Issue number22
DOIs
StatePublished - Nov 25 1982

All Science Journal Classification (ASJC) codes

  • Medicine(all)

Fingerprint Dive into the research topics of 'Attitudes of Those at Risk for Huntington's Disease toward Presymptomatic Provocative Testing'. Together they form a unique fingerprint.

Cite this